DE69535690D1 - Kostimulatorisches T-Zell-Oberflächen-Antigen SLAM - Google Patents

Kostimulatorisches T-Zell-Oberflächen-Antigen SLAM

Info

Publication number
DE69535690D1
DE69535690D1 DE69535690T DE69535690T DE69535690D1 DE 69535690 D1 DE69535690 D1 DE 69535690D1 DE 69535690 T DE69535690 T DE 69535690T DE 69535690 T DE69535690 T DE 69535690T DE 69535690 D1 DE69535690 D1 DE 69535690D1
Authority
DE
Germany
Prior art keywords
slam
costimulatory
cell surface
surface antigen
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69535690T
Other languages
English (en)
Other versions
DE69535690T2 (de
Inventor
Gregorio Aversa
Chia-Chun J Chang
Benjamin G Cocks
Vries Jan E De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/348,792 external-priority patent/US5576423A/en
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DE69535690D1 publication Critical patent/DE69535690D1/de
Publication of DE69535690T2 publication Critical patent/DE69535690T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74Inducing cell proliferation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DE69535690T 1994-12-02 1995-11-29 Kostimulatorisches T-Zell-Oberflächen-Antigen SLAM Expired - Lifetime DE69535690T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/348,792 US5576423A (en) 1994-12-02 1994-12-02 Antibodies to the slam protein expressed on activated T cells
US348792 1994-12-02
US48177795A 1995-06-07 1995-06-07
US481777 1995-06-07
PCT/US1995/014942 WO1996017060A1 (en) 1994-12-02 1995-11-29 Purified genes encoding mammalian cell surface antigens; proteins and antibodies

Publications (2)

Publication Number Publication Date
DE69535690D1 true DE69535690D1 (de) 2008-03-06
DE69535690T2 DE69535690T2 (de) 2009-01-15

Family

ID=26995892

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69535690T Expired - Lifetime DE69535690T2 (de) 1994-12-02 1995-11-29 Kostimulatorisches T-Zell-Oberflächen-Antigen SLAM

Country Status (10)

Country Link
US (1) US6399065B1 (de)
EP (2) EP1867720A3 (de)
JP (2) JPH10510707A (de)
AR (1) AR002004A1 (de)
AT (1) ATE384127T1 (de)
AU (1) AU4365196A (de)
CA (1) CA2206610A1 (de)
DE (1) DE69535690T2 (de)
ES (1) ES2301164T3 (de)
WO (1) WO1996017060A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1522858A1 (de) * 2003-10-10 2005-04-13 Jean-Christophe Roegel Methoden für Selektion von Verbindungen unter Verwendung von Antikörpern mit Aktivität als Agonist, Antagonist oder allosterischen Modulatoren
GB201700621D0 (en) 2017-01-13 2017-03-01 Guest Ryan Dominic Method,device and kit for the aseptic isolation,enrichment and stabilsation of cells from mammalian solid tissue
GB201910605D0 (en) * 2019-07-24 2019-09-04 Immetacyte Ltd Tumour infltracting lymphocyte therapy amd uses thereo
WO2021123832A1 (en) 2019-12-20 2021-06-24 Instil Bio (Uk) Limited Devices and methods for isolating tumor infiltrating lymphocytes and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56145222A (en) * 1980-04-28 1981-11-11 Toshiyuki Hamaoka Improved antibody and its preparation
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US5389520A (en) * 1989-02-21 1995-02-14 Dana-Farber Cancer Institute, Inc. Specific detection of cell surface receptor leukocyte adhesion molecule-1
WO1992000092A1 (en) * 1990-07-02 1992-01-09 Bristol-Myers Squibb Company Ligand for cd28 receptor on b cells and methods
DE122007000078I2 (de) * 1991-06-27 2011-01-13 Bristol Myers Squibb Co CTL4A-Rezeptor, ihn enthaltenden Fusionsproteine und deren Verwendung

Also Published As

Publication number Publication date
WO1996017060A1 (en) 1996-06-06
DE69535690T2 (de) 2009-01-15
AU4365196A (en) 1996-06-19
EP0795014A1 (de) 1997-09-17
EP0795014B1 (de) 2008-01-16
EP1867720A2 (de) 2007-12-19
AR002004A1 (es) 1998-01-07
US6399065B1 (en) 2002-06-04
MX9703956A (es) 1997-09-30
EP1867720A3 (de) 2008-01-09
JPH10510707A (ja) 1998-10-20
ATE384127T1 (de) 2008-02-15
JP2007008958A (ja) 2007-01-18
ES2301164T3 (es) 2008-06-16
CA2206610A1 (en) 1996-06-06

Similar Documents

Publication Publication Date Title
FI20115005A (fi) Melanooma-antigeeni
FI964235A0 (fi) Melanooma-antigeeni
DE69634913D1 (de) Schnittstellenvorrichtung
DE69630487D1 (de) Kupplungsvorrichtung
DE69432921D1 (de) Schnittstelleneinrichtung
HUP0100094A3 (en) Novel surface antigen
NO951073D0 (no) Brönnhode-pakningsanordning
DE69602549D1 (de) Kupplungsvorrichtung
DE59510063D1 (de) Kupplungsvorrichtung
DE69627620D1 (de) Wischgerät
DE59602646D1 (de) Antriebsvorrichtung
NO963191D0 (no) Trykkdrevet fraktureringsinnretning
DE69615249D1 (de) Schnittstelleneinrichtung
IT1281117B1 (it) Dispositivo di attuazione bistabile
DE69535690D1 (de) Kostimulatorisches T-Zell-Oberflächen-Antigen SLAM
DE29503122U1 (de) Sonotrode
NO971642D0 (no) Koblingsanordning
DE69610936T2 (de) Kupplungseinrichtung
DE29519320U1 (de) Wischgerät
DE29501664U1 (de) Auftragvorrichtung
DE69611426T2 (de) Reibungsverbindungsvorrichtung
DE69614935T2 (de) Plattengerät
DE29519900U1 (de) Saugvorrichtung
DE69617416D1 (de) Antriebsvorrichtung
DE59601022D1 (de) Antriebseinrichtung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition